Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1939 EPIPEN and EPIPEN Jr ® ® EPIPEN and EPIPEN Jr EPIPEN (epinephrine injection), Auto-Injector 0.3 mg, EPIPEN Jr (epinephrine injection) Auto-Injector 0.15 mg, for intramuscular or subcutaneous use ® ®
Medication labelWhy this: Advisory · dailymed-prescription
EpiPen and EpiPen Jr are indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. EpiPen and EpiPen Jr are intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. Anaphylactic reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria or angioedema. EpiPen and EpiPen Jr are intended for immediate administration as emergency supportive therapy only and are not a substitute for immediate medical care.
- generic_name
- epinephrine
- product_names
- epinephrine
- ndc
- 64725-0500, 64725-0501, 49502-500, 64725-0500-1, 49502-501, 64725-0501-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en